Newhouse, United Kingdom

Olaf Nimz

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Msd Oss B.v., N.v. Organon. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olaf Nimz. Retrieved from https://idiyas.com/inventor/olaf-nimz-5ewds096

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Olaf Nimz

Introduction

Olaf Nimz is a notable inventor based in Newhouse, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on innovative chemical compounds that have potential therapeutic applications.

Latest Patents

One of his latest patents is for hexafluoroisopropanol derivatives. This invention relates to hexafluoroisopropanol derivatives having the general formula I, which are used in pharmaceutical compositions and have applications in the treatment of atherosclerosis. Another significant patent is for 9-azabicyclo[3.3.1]nonane derivatives. This invention involves a 9-azabicyclo[3.3.1]nonane derivative of formula I, which can be used in pharmaceutical compositions and has therapeutic uses.

Career Highlights

Throughout his career, Olaf Nimz has worked with prominent companies such as MSD Oss B.V. and N.V. Organon. His experience in these organizations has contributed to his expertise in the pharmaceutical industry.

Collaborations

Olaf has collaborated with notable individuals in his field, including Andrew John Cooke and Andrew Stanley Edwards. These collaborations have likely enriched his work and expanded his innovative capabilities.

Conclusion

Olaf Nimz is a distinguished inventor whose work in pharmaceuticals has led to valuable innovations. His patents reflect a commitment to advancing medical treatments and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…